MA39762A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
MA39762A
MA39762A MA039762A MA39762A MA39762A MA 39762 A MA39762 A MA 39762A MA 039762 A MA039762 A MA 039762A MA 39762 A MA39762 A MA 39762A MA 39762 A MA39762 A MA 39762A
Authority
MA
Morocco
Prior art keywords
compounds
preparing
novel compounds
hyper
prophylaxis
Prior art date
Application number
MA039762A
Other languages
French (fr)
Inventor
Daniel Basting
Eckhard Bender
Jens Geisler
Anja Giese
Stefan Golz
Andrea Hägebarth
Philip Lienau
Ningshu Liu
Ursula Mönning
Manfred Möwes
Florian Puehler
Dirk Schneider
William Scott
Franziska Siegel
Kai Thede
Ludwig Zorn
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of MA39762A publication Critical patent/MA39762A/en

Links

Abstract

The present invention relates to inhibitors of the wnt signalling pathways of general formula (i) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative disorder, as a sole agent or in combination with other active ingredients.
MA039762A 2014-03-20 2015-03-18 Novel compounds MA39762A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461968172P 2014-03-20 2014-03-20
EP14185274 2014-09-18

Publications (1)

Publication Number Publication Date
MA39762A true MA39762A (en) 2017-01-25

Family

ID=65628886

Family Applications (1)

Application Number Title Priority Date Filing Date
MA039762A MA39762A (en) 2014-03-20 2015-03-18 Novel compounds

Country Status (5)

Country Link
CL (1) CL2016002368A1 (en)
IL (1) IL247327A0 (en)
MA (1) MA39762A (en)
SV (1) SV2016005282A (en)
ZA (1) ZA201605726B (en)

Also Published As

Publication number Publication date
SV2016005282A (en) 2018-12-05
IL247327A0 (en) 2016-09-29
ZA201605726B (en) 2019-11-27
CL2016002368A1 (en) 2017-03-03

Similar Documents

Publication Publication Date Title
PH12021550792A1 (en) 2-(morpholin-4-yl)-1,7-naphthyridines
PH12016501807A1 (en) Novel compounds
PH12016501581A1 (en) Benzimidazol-2-amines as midh1 inhibitors
PH12017501079A1 (en) 1,3-thiazol-2-yl substituted benzamides
PH12017502001A1 (en) Amido-substituted cyclohexane derivatives
PH12017501133A1 (en) Pyrazolopyridinamines
TN2015000371A1 (en) Substituted imidazopyridazines
PH12016500931A1 (en) Thienopyrimidines as mknk1 and mknk2 inhibitors
PH12016501932A1 (en) Amido-substituted azole compounds
PH12016500054A1 (en) Substituted pyrazolo-pyridinamines
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
WO2014147182A3 (en) Substituted n-biphenyl-3-acetylamino-benzamides and n-[3-(acetylamino)phenyl]-biphenyl-carboxamides and their use as inhibitors of the wnt signalling pathway
PH12020550494A1 (en) Novel pyrazolo-pyrrolo-pyrimidine-dione derivatives as p2x3 inhibitors
MA39762A (en) Novel compounds
TN2014000091A1 (en) Amino-substituted imidazopyridazines